Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Clin Transplant ; 22(4): 284-293, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38742319

ABSTRACT

OBJECTIVES: Splenectomy during liver transplant can affect platelet function. In this study, our primary aim was to assess the perioperative platelet function by rotational thromboelastometry and the effects of splenectomy on platelet function. MATERIALS AND METHODS: We studied 40 consecutive liver transplant recipients with end-stage liver disease (50% as a result of hepatitis C). Patients with splenectomy were compared with patients without splenectomy (n = 20/group). Three platelet function parameters by rotational thromboelastometry were studied: platelet activation with arachidonic acid, platelet activation with adenosine diphosphate, and platelet activation with thrombin receptor-activating peptide 6. Patients were monitored perioperatively and until postoperative day 21. Heparin was infused for 2 days postoperatively (60-180 U/kg/day), followed by administration of subcutaneous low-molecular-weight heparin (40 mg/24 h) on postoperative days 2 and 3 and oral acetylsalicylic acid when platelet count was >50 × 103/µL. RESULTS: Liver disease contributed to low perioperative platelet count and function. Patients showed significant improvement by postoperative day 14 and day 21, particularly after splenectomy. Platelet count was significantly correlated with the 3 platelet function parameters by rotational thromboelastometry (P < .001). Acetyl salicylic acid was required earlier (postoperative day 3) for patients with splenectomy (8/20) but only affected the platelet function represented by platelet activation with arachidonic acid, whereas other platelet activation pathways were less affected. Patients received no transfusions of platelet units. CONCLUSIONS: End-stage liver disease significantly contributed to low platelet function and counts before transplant. Two weeks were required for recovery of patients posttransplant, with further enhancement by splenectomy. Some recipients showed recovery that exceeded the normal reference range, which warranted monitoring. Acetyl salicylic acid only affected 1 platelet activation receptor.


Subject(s)
Blood Coagulation , Blood Platelets , End Stage Liver Disease , Liver Transplantation , Predictive Value of Tests , Splenectomy , Thrombelastography , Humans , Liver Transplantation/adverse effects , Male , Female , Middle Aged , Splenectomy/adverse effects , Treatment Outcome , Blood Coagulation/drug effects , Adult , End Stage Liver Disease/surgery , End Stage Liver Disease/diagnosis , End Stage Liver Disease/blood , Time Factors , Blood Platelets/drug effects , Platelet Activation/drug effects , Platelet Function Tests , Platelet Aggregation Inhibitors/administration & dosage , Anticoagulants/administration & dosage , Platelet Count , Blood Coagulation Tests , Aspirin/administration & dosage , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...